Tetrahydrobiopterin and Total Biopterin Content of Neuroblastoma (N1E‐115, N2A) and Pheochromocytoma (PC‐12) Clones and the Dependence of Catecholamine Synthesis on Tetrahydrobiopterin Concentration in PC‐12 Cells

Abstract

Abstract: Tetrahydrobiopterin content was determined in several clonal cell lines by reversed‐phase HPCL and subsequent electrochemical detection. The same chromatography system was used to determine the total biopterin (tetrahydrobiopterin and 7,8‐dihydrobiopterin) by fluorescence detection. The catecholamine‐producing clones neuroblastoma N1E‐115 and pheochromocytoma PC‐12 contained 96 and 60 ng tetrahydrobiopterin/mg protein, respectively. The corresponding amount for the neuroblastoma clone N2A was 36 ng/mg protein. The tetrahydrobiopterin content in C‐6 glioma cells was below the limit of detection. The total biopterin is about 20% above the tetrahydrobiopterin content. Tetrahydrobiopterin and biopterin from the cells were identified by coelution with standard solutions and by potential‐current relationship or emission and excitation spectra, respectively. Addition of 2,4‐diamino‐6‐hydroxypyrimidine, an inhibitor of biopterin synthesis from GTP, to the culture medium of PC‐12 cells resulted in a dose‐dependent decrease of tetrahydrobiopterin and total biopterin content within 4 h, suggesting that the cells are capable of synthesising the biopterin which was found. A decrease in intracellular tetrahydrobiopterin levels by different concentrations of 2,4‐diamino‐6‐hydroxypyrimidine reduces the cellular production of dihydroxyphenylalanine after inhibition of aromatic L‐amino acid decarboxylase, indicating that the concentration of tetrahydrobiopterin might be a limiting factor for catecholamine synthesis in catecholamine‐producing cells.